Skip to main content
Your session has expired. Reloading...

Amphetamine Screening

€57,-

Individual amphetamine screening with laboratory confirmation.

Certified Lab
Private & Confidential
Fast Results

Add to your order

No referral needed

Added to your order

Click the button to view your cart

Included Substances

1 substances

This test screens for the presence of amphetamines in urine. Detection is typically possible within a window of approximately two to four days after use, though individual variation may occur.

Why this test?

This screening detects amphetamines and related compounds in urine. The approximate detection window is two to four days, though this may vary depending on individual factors such as metabolism, hydration, and dosage. It is worth noting that certain prescription medications, including some used for ADHD, may contain amphetamine-based compounds and could produce a positive screening result.

Who is this test for?

This test may be relevant for:

  • Individuals who wish to verify the presence or absence of amphetamines for their own information
  • People who need a focused, single-substance screening for amphetamines
  • Anyone seeking documentation of an amphetamine-specific screening result

What is tested?

This test measures a single marker:

  • Amphetamines: measured in urine, expressed in ug/l. The test detects the presence of amphetamine and related compounds above the laboratory's reporting threshold. The approximate detection window is two to four days. Note: some prescription medications (such as certain ADHD medications) contain amphetamine-based compounds and may produce a positive result.

What can this test tell you?

A positive result indicates that amphetamines were detected above the laboratory's reporting threshold, suggesting that the substance may have been present in the body within the detection window. A negative result means that amphetamines were not detected above the threshold at the time of sample collection.

If a positive result is obtained, confirmation testing may be performed. It may be relevant to mention any prescription medications to a healthcare provider, as some medications can influence the screening outcome. The test provides information about detection or non-detection and does not indicate dosage or frequency of use.

How is the sample collected?

The test requires a urine sample, collected at a certified sample point (afnamepunt). A mid-stream sample is collected under the guidance of trained personnel. The process is straightforward and typically takes only a few minutes.

When is this test useful?

This test may be considered when:

  • A focused screening for amphetamines is desired
  • Personal insight into whether amphetamines are present is wanted
  • Documentation of an amphetamine-specific screening result is needed

What do the results mean?

The result is reported as detected or not detected. A positive result suggests that amphetamine use may have occurred within the approximate detection window (two to four days). A negative result indicates that the substance was not found above the reporting threshold.

Individual factors such as metabolism, hydration, and prescription medication use may influence the result. If you take prescription medications that contain amphetamine-based compounds, this information may be relevant when discussing results with a healthcare provider.

Preparation

Collect a mid-stream urine sample at the sample point. Hydrate normally beforehand. Over-hydration may dilute the sample and could affect the reliability of the result. If you take prescription medications that could affect the screening, you may wish to note this for reference when discussing results with a healthcare provider.

What happens after the results?

Results are typically available within a few working days. The report indicates whether amphetamines were detected or not detected.

If the initial screening produces a positive result, confirmation testing using a more specific analytical method may be performed. The final report includes the confirmed outcome. A healthcare provider can help interpret the results in context, particularly if prescription medications may have influenced the screening.

Frequently Asked Questions

This screening uses laboratory immunoassay technology designed to detect amphetamines and related compounds. Detection windows typically range from 2-4 days after use, though this may vary based on individual factors and the specific compound.
Certified Lab
Fast Results
Confidential
No Referral Needed

Screening in 4 steps

No referral, no waiting, no questions. Order, test, and receive your results on your dashboard.

Choose your substances

Select a standard panel or build your own screening. Your lab referral is generated instantly.

Receive your lab referral

Within 2-3 hours you'll receive an email from ZorgDomein with a barcode. Orders outside business hours are processed the next business day.

Get tested at a lab near you

Show the barcode on your phone and bring a valid ID. Done in under 15 minutes.

View your report

Assessed by a BIG-registered physician. Results typically within a few business days on your secure dashboard.

Blood test locations

Always a location near you

With more than 650+ certified phlebotomy points across the Netherlands.

650+ locations 12 provinces
View all locations

What We Screen For

This panel screens for 1 substances to give you comprehensive results.

An amphetamines urine test is a qualitative screening that detects the presence of amphetamine, methamphetamine, MDMA (ecstasy), and related compounds or their metabolites in urine. This test covers a broad class of central nervous system stimulants.

Learn more

Related biomarkers

Biomarkers often explored alongside this test for a fuller picture.

Drug Screening

2C-B

A 2C-B urine test is a qualitative screening that detects the presence of 2C-B (4-bromo-2,5-dimethoxyphenethylamine) or its metabolites in urine. 2C-B is a synthetic psychedelic phenethylamine with stimulant and hallucinogenic properties.

Learn more
Drug Screening

3-MMC

A 3-MMC urine test is a qualitative screening that detects the presence of 3-methylmethcathinone (3-MMC) or its metabolites in urine. 3-MMC is a synthetic cathinone with stimulant and empathogenic properties.

Learn more
Drug Screening

6-MAM (Heroin Marker)

A 6-MAM urine test is a qualitative screening that detects the presence of 6-monoacetylmorphine (6-MAM) in urine. 6-MAM is a unique metabolite of heroin (diacetylmorphine) and its presence confirms heroin exposure specifically, rather than general opiate use.

Learn more
Drug Screening

Alcohol (EtG)

An EtG urine test is a qualitative screening that detects the presence of ethyl glucuronide (EtG), a direct metabolite of ethanol. EtG can be detected in urine for up to 80 hours after alcohol consumption, making it a sensitive biomarker for recent alcohol exposure.

Learn more
Drug Screening

Barbiturates

A barbiturates urine test is a qualitative screening that detects the presence of barbiturate compounds or their metabolites in urine. Barbiturates are a class of sedative-hypnotic medications that act on the central nervous system.

Learn more
Drug Screening

Benzodiazepines

A benzodiazepines urine test is a qualitative screening that detects the presence of benzodiazepine compounds or their metabolites in urine. Benzodiazepines are a widely prescribed class of anxiolytic and sedative medications.

Learn more

This test not quite right?

Build your own blood test from 21+ individual biomarkers — choose exactly what you need.

Have a question?

Our team is happy to help. Ask your question and we'll respond as soon as possible.

We typically respond within 24 hours

€57,-

Amphetamine Screening